Loading clinical trials...
Loading clinical trials...
The purpose of this study is to investigate whether the susceptibility of subjects to atherosclerosis is influenced by prior CMV exposure, whether the susceptability to endothelial dysfunction in pati...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
NCT07613294 · Atherosclerosis, Cardiovascular Diseases, and more
NCT05867381 · Air Pollution, Atherosclerosis
NCT06091319 · Acute Coronary Syndrome, Stroke, and more
NCT01399385 · Healthy, Obesity, and more
NCT06939374 · Coronary Arterial Disease (CAD), Plaque, and more
National Heart, Lung and Blood Institute (NHLBI)
Bethesda, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions